Skip to main content
. 2026 Apr 25;26:729. doi: 10.1186/s12885-026-16073-4

Table 1.

The baseline characteristics and difference between the HIPEC and non-HIPEC groups

Before PSM After PSM
level Overall non-HIPEC HIPEC p Overall non-HIPEC HIPEC p
n 166 125 41 120 80 40
Age(years,%) 72.95 ± 7.07 74.09 ± 7.33 69.49 ± 4.87 0.0002 68.93 ± 4.82 69.00 ± 4.90 68.80 ± 4.70 0.84
Sex(%) male 103 (62.1) 79 (63.2) 24 (58.5) 0.727 80 (66.7) 57 (71.3) 23 (57.5) 0.193
famale 63 (38.0) 46 (36.8) 17 (41.5) 40 (33.3) 23 (28.8) 17 (42.5) 0.966
BMI(kg/m2) 23.57 ± 3.37 23.59 ± 3.52 23.51 ± 2.92 0.891 23.38 ± 3.36 23.37 ± 3.59 23.40 ± 2.88 1
NRS(%) <4 154 (92.8) 118 (94.4) 36 (87.8) 0.286 104 (86.7) 69 (86.3) 35 (87.5)
≥ 4 12 (7.2) 7 (5.6) 5 (12.2) 16 (13.3) 11 (13.8) 5 (12.5) 0.47
Hgb (g/L) 116.63 ± 22.32 117.80 ± 21.78 113.07 ± 23.82 0.241 109.98 ± 27.98 108.66 ± 29.86 112.60 ± 23.93 0.306
Alb (g/L) 37.01 ± 3.53 37.12 ± 3.61 36.68 ± 3.27 0.493 36.34 ± 3.45 36.11 ± 3.56 36.80 ± 3.22 1
Diagnosis (%) colon 46 (27.7) 28 (22.4) 18 (43.9) 0.014 51 (42.5) 34 (42.5) 17 (42.5)

sigmoid/

rectum

120 (72.3) 97 (77.6) 23 (56.1) 69 (57.5) 46 (57.5) 23 (57.5) 0.059
Comorbidities (%) no 52 (31.3) 35 (28.0) 17 (41.5) 0.156 79 (65.8) 62 (77.5) 17 (42.5)
yes 114 (68.7) 90 (72.0) 24 (58.5) 41 (34.2) 18 (22.5) 23 (57.5) 1
 Heart disease (%) no 79 (47.6) 43 (34.4) 36 (87.8) < 0.0001 105 (87.5) 70 (87.5) 35 (87.5)
yes 87 (52.4) 82 (65.6) 5 (12.2) 15 (12.5) 10 (12.5) 5 (12.5) 0.84
 Hypertension (%) no 74 (44.6) 51 (40.8) 23 (56.1) 0.126 94 (78.3) 71 (88.8) 23 (57.5) 0.075
yes 92 (55.4) 74 (59.2) 18 (43.9) 26 (21.7) 9 (11.3) 17 (42.5)
 Diabetes (%) no 133 (80.1) 97 (77.6) 36 (87.8) 0.232 106 (88.3) 71 (88.8) 35 (87.5) 1
yes 33 (19.9) 28 (22.4) 5 (12.2) 14 (11.7) 9 (11.3) 5 (12.5)
Respiratory diseases (%) no 162 (97.6) 122 (97.6) 40 (97.6) 1 119 (99.2) 80 (100.0) 39 (97.5) 0.723
yes 4 (2.4) 3 (2.4) 1 (2.4) 1 (0.8) 0 (0.0) 1 (2.5)
 Cerebrovascular diseases(%) no 161 (97.0) 122 (97.6) 39 (95.1) 0.78 117 (97.5) 79 (98.8) 38 (95.0) 0.534
yes 5 (3.0) 3 (2.4) 2 (4.9) 3 (2.5) 1 (1.3) 2 (5.0)
Surgery approach (%) laparoscopy 106 (63.9) 79 (63.2) 27 (65.9) 0.905 81 (67.5) 54 (67.5) 27 (67.5) 1
laparotomy 60 (36.1) 46 (36.8) 14 (34.1) 39 (32.5) 26 (32.5) 13 (32.5)
Organ removal (%) no 149 (89.8) 116 (92.8) 33 (80.5) 0.05 93 (77.5) 61 (76.3) 32 (80.0) 0.817
yes 17 (10.2) 9 (7.2) 8 (19.5) 27 (22.5) 19 (23.8) 8 (20.0)
Blood transfusion (%) no 120 (72.3) 95 (76.0) 25 (61.0) 0.096 69 (57.5) 45 (56.3) 24 (60.0) 0.845
yes 46 (27.7) 30 (24.0) 16 (39.0) 51 (42.5) 35 (43.8) 16 (40.0)
Postoperative complications(%) no 126 (75.9) 94 (75.2) 32 (78.0) 0.873 99 (82.5) 68 (85.0) 31 (77.5) 0.445
yes 40 (24.1) 31 (24.8) 9 (22.0) 21 (17.5) 12 (15.0) 9 (22.5)
 Wound infection (%) no 152 (91.6) 117 (93.6) 35 (85.4) 0.186 108 (90.0) 74 (92.5) 34 (85.0) 0.332
yes 14 (8.4) 8 (6.4) 6 (14.6) 12 (10.0) 6 (7.5) 6 (15.0)
Anastomotic leakage (%) no 165 (99.4) 124 (99.2) 41 (100.0) 1 120 (100.0) 80 (100.0) 40 (100.0) -
yes 1 (0.6) 1 (0.8) 0 (0.0)
Abdominal bleeding(%) no 162 (97.6) 122 (97.6) 40 (97.6) 1 118 (98.3) 79 (98.8) 39 (97.5) 1
yes 4 (2.4) 3 (2.4) 1 (2.4) 2 (1.7) 1 (1.3) 1 (2.5)
Intestinal obstruction (%) no 160 (96.4) 119 (95.2) 41 (100.0) 0.344 116 (96.7) 76 (95.0) 40 (100.0) 0.369
yes 6 (3.6) 6 (4.8) 0 (0.0) 4 (3.3) 4 (5.0) 0 (0.0)
Abdominal complications (%) no 144 (86.8) 106 (84.8) 38 (92.7) 0.305 106 (88.3) 69 (86.3) 37 (92.5) 0.482
yes 22 (13.3) 19 (15.2) 3 (7.3) 14 (11.7) 11 (13.8) 3 (7.5)
 Post cardiovascular events (%) no 159 (95.8) 118 (94.4) 41 (100.0) 0.271 120 (100.0) 80 (100.0) 40 (100.0) -
yes 7 (4.2) 7 (5.6) 0 (0.0)
 Post respiratory complications (%) no 165 (99.4) 124 (99.2) 41 (100.0) 1 120 (100.0) 80 (100.0) 40 (100.0) -
yes 1 (0.6) 1 (0.8) 0 (0.0)
Lower limb thrombosis (%) no 162 (97.6) 121 (96.8) 41 (100.0) 0.567 120 (100.0) 80 (100.0) 40 (100.0) -
yes 4 (2.4) 4 (3.2) 0 (0.0)
Other complications (%) no 156 (94.0) 115 (92.0) 41 (100.0) 0.136 119 (99.2) 79 (98.8) 40 (100.0) 1
yes 10 (6.0) 10 (8.0) 0 (0.0) 1 (0.8) 1 (1.3) 0 (0.0)
Postoperative length of stay 9.74 ± 5.13 9.66 ± 5.50 9.95 ± 3.84 0.757 8.37 ± 3.43 8.16 ± 3.06 8.79 ± 4.08 0.392
Histological type Adenocarcinoma 148 (89.2) 111 (88.8) 37 (90.2) 0.796 107 (89.2) 71 (88.8) 36 (90.0) 0.836
Mucinous carcinoma 18 (10.8) 14 (11.2) 4 (9.8) 13 (10.8) 9 (11.3) 4 (10.0)
Difference degree (%)

Moderately/highly

differentiated

122 (73.5) 94 (75.2) 28 (68.3) 0.506 81 (67.5) 54 (67.5) 27 (67.5) 1
Poorly differentiated 44 (26.5) 31 (24.8) 13 (31.7) 39 (32.5) 26 (32.5) 13 (32.5)
pT (%) T3 107 (64.5) 96 (76.8) 11 (26.8) < 0.0001 33 (27.5) 22 (27.5) 11 (27.5) 1
T4 59 (35.5) 29 (23.2) 30 (73.2) 87 (72.5) 58 (72.5) 29 (72.5)
Total degree(%) II 88 (53.0) 70 (56.0) 18 (43.9) 0.243 67 (55.8) 49 (61.3) 18 (45.0) 0.135
III 78 (47.0) 55 (44.0) 23 (56.1) 53 (44.2) 31 (38.8) 22 (55.0)
ASA(%) 1 38 (22.9) 29 (23.2) 9 (22.0) 0.951 38 (31.7) 29 (36.3) 9 (22.5) 0.055
2 106 (63.9) 79 (63.2) 27 (65.9) 75 (62.5) 49 (61.3) 26 (65.0)
3 22 (13.3) 17 (13.6) 5 (12.2) 7 (5.8) 2 (2.5) 5 (12.5)
pN(%) N0 91 (54.8) 71 (56.8) 20 (48.8) 0.475 69 (57.5) 49 (61.3) 20 (50.0) 0.327
N1/2 75 (45.2) 54 (43.2) 21 (51.2) 51 (42.5) 31 (38.8) 20 (50.0)

“-” indicates that the event did not occur in the matched cohort after adjustment, precluding the calculation of the P-value

Bold values indicate statistical significance (P < 0.05)